PhD positions to advance psychedelic therapy research in mental health

Overview

16 PhD positions to advance psychedelic therapy research in mental health. Deadline 11 Feb ’26. Published 26 Jan ’26. Vacancy .

Ethics in health sciences;
Medical sciences;
Neurosciences;
Psychological sciences.

INTEGRATE is an international, multidisciplinary Marie Sklodowska-Curie Doctoral Network funded by the European Commission under Horizon Europe (Grant agreement : ), coordinated by the University Center for Psychiatry (UCP) at the University Medical Center Groningen (UMCG). The network aims to train a new generation of interdisciplinary experts to implement psychedelic therapy (PT) in healthcare, addressing challenges such as mechanisms of action, clinical standards, regulatory obstacles, and ethical considerations.

The consortium includes 11 academic beneficiaries and 23 associated partners across Europe and worldwide, offering cutting edge research, training schools, and secondments in industry, civil society organizations, regulatory agencies, and more.

The network will provide scientific and translational skills training to 16 Doctoral Candidates (DCs) with three-year fixed-term positions, divided over the 11 beneficiaries in 9 countries in Europe. Each DC will work on an individual PhD project, combining cutting-edge science with training in personal development, ethics, regulation, and societal impact. The program offers excellent supervision, interdisciplinary collaboration, and secondments across academic, clinical, and industry partners to prepare DCs as future leaders in this emerging field.

More information about the network can be found on the consortium website:(Use the "Apply for this Job" box below)..

Available DC positions

• WP2:
  Foundational Research – Mechanisms of Action & Understanding Psychedelic Experiences
• DC1:
  The antidepressant efficacy of psilocybin from a pathophysiological perspective (UMCG, The Netherlands)
• DC2:
  Understanding the neurobiology of psychedelic therapy from synapse to behavior (Uppsala University, Sweden)
• DC3:
  Identification of EEG and fMRI biomarkers with potential predictive value for psychedelics’ antidepressant effects (NIMH, Czechia)
• DC4:
  Mapping the subjective phenomenology of therapeutic and challenging experiences in psychedelic therapy (UMCG, The Netherlands)
• DC5:
  Psychedelics, attachment-related changes, and mental health outcomes (Stockholm University, Sweden)
• DC6:
  Sex/gender differences in psychedelic psychopharmacology (NKUA, Greece)
• WP3:
  Clinical Research – Optimizing Safety and Efficacy
• DC7:
  The role of music and psychotherapeutic support in psychedelic therapy (UCPH, Denmark)
• DC8:
  Set and setting in clinical psychedelic research (INSERM, France)
• DC9:
  Psychotherapy process and psychological intervention techniques in psychedelic therapy: safety and efficacy (Champalimaud Foundation, Portugal)
• DC10:
  Methodological challenges in clinical psychedelic research (Leiden University, The Netherlands)
• DC11:
  Health economics of psychedelic therapy (Uppsala University, Sweden)
• DC12:
  Analyzing the obstacles and opportunities of different regulatory pathways to patient access for psychedelic therapies (UCPH, Denmark)
• DC15*:
  Evaluating the impact of controlled self-experience with psychedelics in therapist training. A clinical trial (UB, Switzerland)
• DC16*:
  Clinical development of psychedelic-assisted therapy: transdiagnostic mechanisms and contextual factors (UZH, Switzerland)
• WP4:
  Ethical, Legal, Societal Implications
• DC13:
  Identifying ethical, legal and societal challenges and opportunities for applying psychedelic therapy (UG, NL)
• DC14:
  Harmonizing Ethical Regulation of Psychedelic Therapy with Broader Medical Practices (Charité, DE)
• * Swiss-funded positions

Detailed information on the individual DC projects can be found on the consortium website:.

• Master’s degree in a relevant field (e.g., neuroscience, psychology, psychiatry, pharmacology, ethics, law) or a Medical Degree, allowing enrolment in a PhD program at the hiring beneficiary
• Strong motivation to work in psychedelic therapy research
• Excellent communication skills and ability to work in a team
• Proficiency in English (C1/C2 level)
• Compliance with EU MSCA DN rules:
• Applicants must not have…